MedTrace Logo

Evaluation of the Performance of Investigational Contact Lenses in a Presbyopic Population

NCT01763047 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 298

Last updated 2018-06-19

Study results available
· View outcomes & findings →

Summary

The objective of this study is to evaluate the performance of a novel multifocal lens system.

Conditions

Interventions

DEVICE

etafilcon A

To be worn in a daily wear modality for a minimum of 6 hours per day.

DEVICE

lotrafilcon B

Lenses will be worn in a reuseable modality; cleaned and disinfected each night.

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01763047 on ClinicalTrials.gov